The study authors developed an economic model in which patients receiving THA via the anterior approach were compared to a matched cohort of primary THA cases identified from Medicare claims. Costs were derived from Medicare claims and were adjusted to account for nationwide payer mix.
Healthcare costs over 90-days postoperatively were $17,763 for anterior approach patients and $23,969 with the control, a $6,206 difference per patient.
The cost savings with the anterior approach were mostly attributable to:
- Lower per-patient costs of the index hospitalization: $13,578 for anterior approach versus $16,017 for control
- Post-acute care costs: $3,123 versus $6,037
- Hospital readmissions: $700 versus $1,584
More articles on orthopedics:
Ortho Consulting Group forms new partnership with The Limbless Association: 4 notes
Orthopedic surgeon to know: Dr. Mark Romness of University of Virginia Health System
Orthopedic surgeon Dr. Michaela Schneiderbauer joins new practice — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
